Phenylhexyl Isothiocyanate Inhibits Myeloma Cell Growth
Author Information
Author(s): Lu Quanyi, Lin Xianghua, Feng Jean, Zhao Xiangmin, Gallagher Ruth, Lee Marietta Y, Chiao Jen-Wei, Liu Delong
Primary Institution: New York Medical College
Hypothesis
Does phenylhexyl isothiocyanate (PHI) function as both a histone deacetylase inhibitor and a hypomethylating agent to inhibit myeloma cell growth?
Conclusion
PHI has dual epigenetic effects on p16 hypomethylation and histone hyperacetylation in myeloma cells, targeting critical processes of myeloma proliferation.
Supporting Evidence
- PHI inhibited the proliferation of myeloma cells and induced apoptosis at concentrations as low as 0.5 μM.
- Cell cycle analysis showed that PHI caused G1-phase arrest in RPMI8226 cells.
- PHI induced p16 hypomethylation and histone H3 hyperacetylation in a concentration-dependent manner.
- PHI significantly reduced IL-6 receptor expression and VEGF production in myeloma cells.
Takeaway
A chemical called PHI can help stop cancer cells from growing by changing how their genes are turned on and off.
Methodology
The study involved treating the RPMI8226 myeloma cell line with PHI and analyzing cell proliferation, apoptosis, DNA methylation, and histone acetylation.
Limitations
The study focused on a single myeloma cell line, RPMI8226, which may limit the generalizability of the findings.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website